{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T15:47:06Z","timestamp":1784130426392,"version":"3.55.0"},"reference-count":24,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T00:00:00Z","timestamp":1556668800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Magnetic Research Inc."}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Magnetic Resonance Imaging"],"published-print":{"date-parts":[[2019,5]]},"DOI":"10.1016\/j.mri.2019.01.001","type":"journal-article","created":{"date-parts":[[2019,1,10]],"date-time":"2019-01-10T17:16:47Z","timestamp":1547140607000},"page":"76-81","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["The use of a binary chelate formulation: Could gadolinium based linear contrast agents be rescued by the addition of zinc selective chelates?"],"prefix":"10.1016","volume":"58","author":[{"given":"Wendell","family":"Gibby","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8473-1876","authenticated-orcid":false,"given":"Wes","family":"Parish","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ray M.","family":"Merrill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diego","family":"Fernandez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher R.","family":"Anderson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Merchel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8484-4830","authenticated-orcid":false,"given":"Ryan","family":"Parr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.mri.2019.01.001_bb0005","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s12325-015-0275-4","article-title":"25\u202fyears of contrast-enhanced MRI: developments, current challenges and future perspectives","volume":"33","author":"Lohrke","year":"2016","journal-title":"Adv Ther"},{"key":"10.1016\/j.mri.2019.01.001_bb0010","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1097\/RMR.0000000000000109","article-title":"Incidence and risk factors for gadolinium-based contrast agent immediate reactions","volume":"25","author":"Costello","year":"2016","journal-title":"Top Magn Reson Imaging"},{"issue":"31","key":"10.1016\/j.mri.2019.01.001_bb0015","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1097\/01.rli.0000112789.57341.01","article-title":"Comparison of Gd DTPA-BMA (Omniscan) versus Gd HP-DO3A (ProHance) retention in human bone tissue by inductively coupled plasma atomic emission spectroscopy","volume":"39","author":"Gibby","year":"2004","journal-title":"Invest Radiol"},{"issue":"3","key":"10.1016\/j.mri.2019.01.001_bb0020","doi-asserted-by":"crossref","DOI":"10.1097\/01.rli.0000186569.32408.95","article-title":"Comparison of Gd(DTPA-BMA) (Omniscan) versus Gd(HP-DO3A) (ProHance) relative to gadolinium retention in human bone tissue by inductively coupled plasma mass spectroscopy","volume":"41","author":"White","year":"2006","journal-title":"Invest Radiol"},{"issue":"12","key":"10.1016\/j.mri.2019.01.001_bb0025","doi-asserted-by":"crossref","first-page":"2619","DOI":"10.1007\/s00330-006-0495-8","article-title":"Nephrogenic systemic fibrosis: a serious late adverse reaction to gadodiamide","volume":"16","author":"Thomsen","year":"2006","journal-title":"Eur Radiol"},{"key":"10.1016\/j.mri.2019.01.001_bb0030","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1148\/radiol.2015150337","article-title":"Gadolinium retention in the in the dentate nucleus and global pallidus is dependent on the class of contrast agents","volume":"275","author":"Radbruch","year":"2015","journal-title":"Radiology"},{"issue":"7","key":"10.1016\/j.mri.2019.01.001_bb0035","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1097\/RLI.0000000000000252","article-title":"Macrocyclic and other non-group 1 gadolinium contrast agents deposit low levels of gadolinium in brain and bone tissue: preliminary results from 9 patients with normal renal function","volume":"51","author":"Murata","year":"2016","journal-title":"Invest Radiol"},{"issue":"3","key":"10.1016\/j.mri.2019.01.001_bb0040","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1002\/jmri.25822","article-title":"Differences in gadolinium retention after repeated injections of macrocyclic MR contrast agents to rats","volume":"47","author":"Bussi","year":"2018","journal-title":"J Magn Reson Imaging"},{"issue":"1","key":"10.1016\/j.mri.2019.01.001_bb0045","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1148\/radiol.2461071267","article-title":"Response to the FDA's May 23, 2007, nephrogenic systemic fibrosis update","volume":"245","author":"Kanal","year":"2008","journal-title":"Radiology"},{"issue":"6","key":"10.1016\/j.mri.2019.01.001_bb0060","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1097\/RLI.0000000000000344","article-title":"Histology and gadolinium distribution in the rodent brain after the administration of cumulative high doses of linear and macrocyclic gadolinium-based contrast agents","volume":"52","author":"Lohrke","year":"2017","journal-title":"Invest Radiol"},{"key":"10.1016\/j.mri.2019.01.001_bb0065","doi-asserted-by":"crossref","first-page":"229","DOI":"10.2214\/AJR.15.15842","article-title":"Gadolinium in humans: a family of disorders","volume":"201","author":"Smelka","year":"2016","journal-title":"AJR"},{"issue":"12","key":"10.1016\/j.mri.2019.01.001_bb0070","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1097\/00004424-199612000-00001","article-title":"Human in vivo comparative study of zinc and copper transmetallation after administration of magnetic resonance imaging contrast agents","volume":"31","author":"Puttagunta","year":"1996","journal-title":"Invest Radiol"},{"issue":"6","key":"10.1016\/j.mri.2019.01.001_bb0075","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1097\/00004424-199506000-00008","article-title":"Biodistribution of radiolabeled, formulated gadopentate, gadoteridol, gadoterate, and gadodiamide in mice and rats","volume":"30","author":"Tweedle","year":"1995","journal-title":"Invest Radiol"},{"issue":"2","key":"10.1016\/j.mri.2019.01.001_bb0080","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1148\/radiol.2017161594","article-title":"Comparison of gadolinium concentrations with multiple rat organs after intravenous administration of linear versus macrocyclic gadolinium chelates","volume":"285","author":"McDonald","year":"2017","journal-title":"Radiology"},{"issue":"10","key":"10.1016\/j.mri.2019.01.001_bb0085","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1097\/00004424-199610000-00003","article-title":"Comparative transmetallation kinetics and thermodynamic stability of gadolinium-DTPA bis-glucosamide and other magnetic resonance imaging contrast media","volume":"31","author":"Puttagunta","year":"1996","journal-title":"Invest Radiol"},{"key":"10.1016\/j.mri.2019.01.001_bb0090","series-title":"Presented at the 12th International Scientific Meeting of the Science of Magnetic Research in Medicine, 1993, August 14\u201320, New York, New York","article-title":"Gd-DTPA bisglucosamide, a new non-ionic contrast agent with hepatic and renal affinity","author":"Puttagunta","year":"1993"},{"issue":"1","key":"10.1016\/j.mri.2019.01.001_bb0095","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1210\/endo-72-1-117","article-title":"Skeletal maturation in rats with special reference to order and time of epiphyseal closure","volume":"72","author":"Joss","year":"1963","journal-title":"Endocrinology"},{"issue":"12","key":"10.1016\/j.mri.2019.01.001_bb0105","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1097\/RLI.0b013e3181852171","article-title":"Stability of gadolinium-based magnetic resonance imaging contrast agents in human serum at 37\u202f\u00b0C","volume":"43","author":"Frenzel","year":"2008","journal-title":"Invest Radiol"},{"issue":"6","key":"10.1016\/j.mri.2019.01.001_bb0110","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1002\/jmri.21966","article-title":"Primer on gadolinium chemistry","volume":"30","author":"Sherry","year":"2009","journal-title":"J Magn Reson Imaging"},{"key":"10.1016\/j.mri.2019.01.001_bb0115","doi-asserted-by":"crossref","DOI":"10.1098\/rsta.2017.0180","article-title":"Biological effects of MRI contrast agents: gadolinium retention, potentialmechanisms and a role for phosphorus","volume":"375","author":"Garcia","year":"2017","journal-title":"Philos Trans A Math Phys Eng Sci"},{"issue":"7","key":"10.1016\/j.mri.2019.01.001_bb0120","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1016\/0306-4522(82)90019-7","article-title":"The gadolinium ion: a potent blocker of calcium channels and catecholamine release from cultured chromaffin cells","volume":"7","author":"Bourne","year":"1982","journal-title":"Neuroscience"},{"key":"10.1016\/j.mri.2019.01.001_bb0125","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.chemosphere.2013.11.031","article-title":"Mitochondrial dysfunction induced by different concentrations of gadolinium ion","volume":"100","author":"Zhao","year":"2014","journal-title":"Chemosphere"},{"key":"10.1016\/j.mri.2019.01.001_bb0130","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1007\/s10534-016-9931-7","article-title":"Gadolinium-based contrast agent toxicity: a review of known and proposed mechanisms","volume":"29","author":"Rogosnitzky","year":"2016","journal-title":"Biometals"},{"key":"10.1016\/j.mri.2019.01.001_bb0135","author":"FDA"}],"container-title":["Magnetic Resonance Imaging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0730725X18303230?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0730725X18303230?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,3,1]],"date-time":"2019-03-01T18:36:49Z","timestamp":1551465409000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0730725X18303230"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5]]},"references-count":24,"alternative-id":["S0730725X18303230"],"URL":"https:\/\/doi.org\/10.1016\/j.mri.2019.01.001","relation":{},"ISSN":["0730-725X"],"issn-type":[{"value":"0730-725X","type":"print"}],"subject":[],"published":{"date-parts":[[2019,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The use of a binary chelate formulation: Could gadolinium based linear contrast agents be rescued by the addition of zinc selective chelates?","name":"articletitle","label":"Article Title"},{"value":"Magnetic Resonance Imaging","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mri.2019.01.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}